Collectively, our findings establish the myeloid‐derived LGALS9‐P4HB interaction as a crucial mediator of gastric cancer metastatic colonisation through modulation of lipid metabolism, suggesting a potential therapeutic target for metastatic gastric cancer. The gene discussed is LGALS9; the disease is gastric cancer.